Basingstoke and North Hampshire Hospital is a 450-bed National Health Service hospital in Basingstoke, Hampshire, England run by Hampshire Hospitals NHS Foundation Trust. It employs around 2,800 staff.

There are 806 (Trustwide, Quarter 3, 2018) beds in Basingstoke and North Hampshire NHS Foundation Trust.

During the past decade, Basingstoke and North Hampshire NHS Foundation Trust conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 11 clinical trials were completed, i.e. on average, 40.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Basingstoke and North Hampshire NHS Foundation Trust" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 4 trials, followed by "University College, London" with 4 trials sponsored, "Bayer" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Basingstoke and North Hampshire NHS Foundation Trust" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator and "Takeda" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Basingstoke and North Hampshire NHS Foundation Trust" are "Prostate Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Lymphoma" (4 trials), "Metastatic Cancer" (4 trials) and "Multiple Myeloma" (4 trials). Many other conditions were trialed in "Basingstoke and North Hampshire NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Basingstoke and North Hampshire NHS Foundation Trust" are "Drug" (47 trials), "Procedure" (19 trials), "Other" (11 trials), "Biological" (10 trials) and "Device" (8 trials). Other intervention types were less common.

The name of intervention was led by "quality-of-life assessment" (8 trials), "adjuvant therapy" (7 trials), "capecitabine" (6 trials), "cyclophosphamide" (6 trials) and "Placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Basingstoke and North Hampshire NHS Foundation Trust" are 58 trials for "All" genders, 8 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Basingstoke and North Hampshire NHS Foundation Trust". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Basingstoke and North Hampshire NHS Foundation Trust, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Basingstoke and North Hampshire NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".